Form 4: Forte Biosciences Director Acquires Stock Options

Shivpreet Singh Kapoor, a director at Forte Biosciences, acquired stock options for 2,000 shares on September 17, 2024.

Summary

• This is a Form 4 filing indicating a change in beneficial ownership for Shivpreet Singh Kapoor, a director at Forte Biosciences, Inc.
• On September 17, 2024, Kapoor acquired stock options for 2,000 shares of common stock at an exercise price of $7.07 per share.
• The options vest in equal monthly installments over 36 months, contingent upon Kapoor's continued service as a Service Provider, and will be fully vested on the third anniversary of the grant date.
• The expiration date for these options is September 17, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of stock options, which can be seen as a positive sign of confidence, but it's not a major event.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.

Key Dates